Probenecid

This classification denotes a uricosuric agent with the molecular formula C13H19NO4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PO572Z7917, chemically known as 4-(n,n-dipropylsulfamoyl)benzoesaeure but generally known as probenecid, which bears US NIH Compound Identifier 4911. European Medicines Agency schedules Probenecid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10053MIG. The term PROBENECID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 13, No. 12, 1959, List 3). World Health Organization schedules probenecid in its Anatomical Therapeutic Chemical (ATC) Classification. PROBENECID is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule probenecid under HS 29350090 and SITC 51580. As of Q4 2014, PROBENECID remains the US FDA Preferred Term for this commodity. Probenecid bears US NLM identifiers UMLS ID C0033209 and NCI Concept Code C772. SMILES: S(=O)(=O)(N(CCC)CCC)C1CCC(CC1)C(=O)O.